The role of efflux pumps in macrolide resistance in Mycobacterium avium complex

International Journal of Antimicrobial Agents

Volumn 34, Issue 6, 2009, Pages 529-533

  Rodrigues, Liliana ^a   Sampaio, Daniela ^a   Couto, Isabel ^a,b   Machado, Diana ^a   Kern, Winfried V ^c   Amaral, Leonard ^a   Viveiros, Miguel ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Efflux pump inhibitors; Efflux pumps; Macrolide resistance; Mycobacterium avium complex; Phenothiazines; Real time fluorometry

Indexed keywords

CHLORPROMAZINE; CLARITHROMYCIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; THIORIDAZINE; VERAPAMIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; FLUOROMETRY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM AVIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSPORT KINETICS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CHLORPROMAZINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; THIORIDAZINE; UNCOUPLING AGENTS; VERAPAMIL;

EID: 70350375726     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.07.010     Document Type: Article

References (26)

1. Primm T.P., Lucero C.A., and Falkinham III J.O. Health impacts of environmental mycobacteria. Clin Microbiol Rev 17 (2004) 98-106
2. Guthertz L.S., Damsker B., Bottone E.J., Ford E.G., Midura T.F., and Janda J.M. Mycobacterium avium and Mycobacterium intracellulare infection in patients with and without AIDS. J Infect Dis 160 (1989) 1037-1041
3. Griffith D.E. Therapy of nontuberculous mycobacterial disease. Curr Opin Infect Dis 20 (2007) 198-203
4. Field S.K., Fisher D., and Cowie R.L. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 126 (2004) 566-581
5. Inderlied C.B., Kemper C.A., and Bermudez L.E.M. The Mycobacterium avium complex. Clin Microbiol Rev 6 (1993) 266-310
6. Tsang A.Y., Denner J.C., Brennan P.J., and McClatchy J.K. Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates. J Clin Microbiol 30 (1992) 479-484
7. Yakrus M.A., and Good R.C. Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol 28 (1990) 926-929
8. Turenne C.Y., Wallace Jr. R., and Behr M.A. Mycobacterium avium in the postgenomic era. Clin Microbiol Rev 20 (2007) 205-229
9. Jarlier V., and Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123 (1994) 11-18
10. Tomioka H. Present status and future prospects of chemotherapeutics for intractable infections due to Mycobacterium avium complex. Curr Drug Discov Technol 1 (2004) 255-268
11. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. vol. 23. Document M24-A. Wayne, PA: CLSI; 2003.
12. Viveiros M., Leandro C., and Amaral L. Mycobacterial efflux pumps and chemotherapeutic implications. Int J Antimicrob Agents 22 (2003) 274-278
13. De Rossi E., Ainsa J.A., and Riccardi G. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev 30 (2006) 36-52
14. Doucet-Populaire F., Buriankova K., Weiser J., and Pernodet J.L. Natural and acquired macrolide resistance in mycobacteria. Curr Drug Targets Infect Disord 2 (2002) 355-370
15. Amaral L., Martins M., and Viveiros M. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps. J Antimicrob Chemother 59 (2007) 1237-1246
16. Silva P.E., Bigi F., Santangelo M.P., Romano M.I., Martín C., Cataldi A., et al. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob Agents Chemother 45 (2001) 800-804
17. Viveiros M., Portugal I., Bettencourt R., Victor T.C., Jordaan A.M., Leandro C., et al. Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 46 (2001) 2804-2810
18. Viveiros M., Martins M., Couto I., Kristiansen J.E., Molnar J., and Amaral L. The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patient. In Vivo 19 (2005) 733-736
19. Rodrigues L., Wagner D., Viveiros M., Sampaio D., Couto I., Vavra M., et al. Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis. J Antimicrob Chemother 61 (2008) 1076-1082
20. Kent P.T., and Kubica G.P. Public health mycobacteriology: a guide for the level III laboratory (1985), US Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA
21. Viveiros M., Martins A., Paixão L., Rodrigues L., Martins M., Couto I., et al. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method. Int J Antimicrob Agents 31 (2008) 458-462
22. Jamal M.A., Maeda S., Nakata N., Kai M., Fukuchi K., Kashiwabara Y., et al. Molecular basis of clarithromycin resistance in Mycobacterium avium-intracellulare complex. Tuber Lung Dis 80 (2000) 1-4
23. Nash K.A., and Inderlied C.B. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 39 (1995) 2625-2630
24. Meier A., Heifets L., Wallace Jr. R.J., Zhang Y., Brown B.A., Sander P., et al. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis 174 (1996) 354-360
25. Griffith D.E., Brown-Elliott B.A., Langsjoen B., Zhang Y., Pan X., Girard W., et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 174 (2006) 928-934
26. Heifets L.B. Clarithromycin against Mycobacterium avium complex infections. Tuber Lung Dis 77 (1996) 19-26